Embodying the avatar of an omnipotent agent modulates the perception of one's own abilities and enhances feelings of invulnerability.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 12 2022
Historique:
received: 27 07 2022
accepted: 08 12 2022
entrez: 14 12 2022
pubmed: 15 12 2022
medline: 17 12 2022
Statut: epublish

Résumé

Immersive virtual reality can give people the illusion of owning artificial bodies (i.e., avatars) and controlling their actions. Tellingly, people appear to adhere to the newly embodied entities not just on the basis of physical traits but also behaving accordingly with the hallmarks of the represented characters. In two studies we pushed the limits of this process by testing if one's own sense of power could be affected by embodying the anthropomorphic representation of the Christian God, that is considered an omnipotent entity. A human Muscled and a Normotype avatar were used as controls. Results showed that participants embodying the God-avatar: (i) reacted to a threatening event compromising their physical safety by exhibiting a lower skin conductance response and heart rate deceleration compared to the Normotype-control avatar (Study 1); (ii) estimated they had more physical abilities compared to both the Normotype-control and the Muscled-control avatars (Study 2). Taken together, our findings suggest that embodying an omnipotent agent may exert an influence on people's perception of their own limits and capabilities, nourishing feelings of physical invulnerability and strength. Our study indicates that effectively embodying virtual role models may boost achievements and have translational implications in the field of empowerment.

Identifiants

pubmed: 36517558
doi: 10.1038/s41598-022-26016-1
pii: 10.1038/s41598-022-26016-1
pmc: PMC9751071
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21585

Informations de copyright

© 2022. The Author(s).

Références

Cereb Cortex. 2016 Dec;26(12):4450-4460
pubmed: 27733537
Sci Rep. 2017 Aug 29;7(1):9637
pubmed: 28851953
Q J Exp Psychol (Hove). 2022 Mar;75(3):461-474
pubmed: 34169751
Front Robot AI. 2018 Jun 22;5:74
pubmed: 33500953
Conscious Cogn. 2019 Jan;67:86-97
pubmed: 30553938
Biometrics. 1997 Sep;53(3):983-97
pubmed: 9333350
Proc Biol Sci. 2003 Jul 22;270(1523):1499-506
pubmed: 12965016
Sci Rep. 2016 Jul 01;6:28879
pubmed: 27364767
Conscious Cogn. 2013 Sep;22(3):779-87
pubmed: 23727712
Front Hum Neurosci. 2015 Mar 24;9:141
pubmed: 25852524
J Psychopathol Behav Assess. 2022;44(1):39-50
pubmed: 35221465
J Neurophysiol. 2020 Jan 1;123(1):420-427
pubmed: 31800367
Sci Rep. 2015 Sep 29;5:13948
pubmed: 26415748
Front Hum Neurosci. 2013 Jul 31;7:438
pubmed: 23914172
J Neurosci. 2022 Jan 26;42(4):692-701
pubmed: 34862188
Front Hum Neurosci. 2016 Nov 29;10:601
pubmed: 27965555
PLoS One. 2011 Jan 19;6(1):e16128
pubmed: 21283823
Front Hum Neurosci. 2014 Sep 11;8:693
pubmed: 25309383
Sci Rep. 2018 Feb 9;8(1):2692
pubmed: 29426819
J Affect Disord. 2000 Dec;61(3):137-59
pubmed: 11163418
iScience. 2022 Apr 27;25(5):104320
pubmed: 35602961
PLoS One. 2010 May 12;5(5):e10564
pubmed: 20485681
IEEE Trans Vis Comput Graph. 2013 Apr;19(4):597-605
pubmed: 23428444
Front Psychol. 2018 Jun 11;9:917
pubmed: 29942270
Front Hum Neurosci. 2008 Aug 20;2:6
pubmed: 18958207
Neuropsychologia. 2014 May;57:93-100
pubmed: 24657712
Eur J Neurosci. 2005 May;21(9):2505-12
pubmed: 15932607
J Clin Med. 2019 Dec 30;9(1):
pubmed: 31906009
Expert Rev Med Devices. 2018 Feb;15(2):107-117
pubmed: 29313388
Front Psychol. 2013 Jun 05;4:328
pubmed: 23761778
Sci Rep. 2021 Jan 26;11(1):2221
pubmed: 33500486
Psychol Res. 2021 Apr;85(3):926-938
pubmed: 32524205
PLoS One. 2017 Apr 24;12(4):e0174965
pubmed: 28437469
Psychol Sci. 2011 Mar;22(3):325-30
pubmed: 21303990
Cogn Sci. 2016 Jan;40(1):121-44
pubmed: 25807973
PLoS One. 2008;3(12):e3832
pubmed: 19050755
Front Robot AI. 2018 Aug 23;5:91
pubmed: 33500970
PLoS One. 2018 Jun 11;13(6):e0198745
pubmed: 29889879
J Neurosci Methods. 2010 Jun 30;190(1):80-91
pubmed: 20451556
Neurosci Biobehav Rev. 2014 Nov;47:165-76
pubmed: 25108035
Sci Rep. 2015 Sep 10;5:13899
pubmed: 26354311
Brain Res. 2000 Mar 10;858(2):440-5
pubmed: 10708699
PLoS One. 2010 Apr 29;5(4):e10381
pubmed: 20454463
Sci Rep. 2015 Nov 25;5:17139
pubmed: 26602036
J Pers Soc Psychol. 2007 Nov;93(5):699-710
pubmed: 17983295
PLoS One. 2019 Jan 3;14(1):e0209899
pubmed: 30605454
Psychophysiology. 2005 May;42(3):255-60
pubmed: 15943678
Eur J Neurosci. 2017 May;45(9):1141-1151
pubmed: 28222235
Sci Rep. 2020 Mar 25;10(1):5412
pubmed: 32214171
J Pers Soc Psychol. 2020 Dec;119(6):1290-1315
pubmed: 31999155
Nat Neurosci. 2001 Apr;4(4):437-41
pubmed: 11276236
Front Psychol. 2017 Apr 07;8:456
pubmed: 28439244
Front Hum Neurosci. 2019 Aug 21;13:279
pubmed: 31551731
Nature. 1998 Feb 19;391(6669):756
pubmed: 9486643
J Neurophysiol. 2016 Dec 1;116(6):2656-2662
pubmed: 27655965
Exp Brain Res. 2015 Apr;233(4):1247-59
pubmed: 25618006
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12846-51
pubmed: 23858436

Auteurs

Althea Frisanco (A)

Fondazione Istituto Italiano Di Tecnologia (IIT), Sapienza University of Rome and Center for Life Nano- & Neuroscience, Rome, Italy. althea.frisanco@uniroma1.it.
IRCCS Santa Lucia Foundation, Rome, Italy. althea.frisanco@uniroma1.it.

Michael Schepisi (M)

Fondazione Istituto Italiano Di Tecnologia (IIT), Sapienza University of Rome and Center for Life Nano- & Neuroscience, Rome, Italy.
IRCCS Santa Lucia Foundation, Rome, Italy.

Gaetano Tieri (G)

IRCCS Santa Lucia Foundation, Rome, Italy.
Virtual Reality Lab, Unitelma Sapienza University, Rome, Italy.

Salvatore Maria Aglioti (SM)

Fondazione Istituto Italiano Di Tecnologia (IIT), Sapienza University of Rome and Center for Life Nano- & Neuroscience, Rome, Italy. salvatoremaria.aglioti@uniroma1.it.
IRCCS Santa Lucia Foundation, Rome, Italy. salvatoremaria.aglioti@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH